In response to the growing impact of the COVID-19 Coronavirus in Europe, a number of countries have implemented national controls to restrict the export of medicines and medical equipment, such as face masks, gloves, and protective clothing. Over the weekend, the EU Commission reviewed actions taken by Member States and,…
While, the full impact of the COVID-19 coronavirus outbreak and the resulting emergency measures on international trade remains…
Baker McKenzie’s EMEA Employment and Compensation Team is pleased to provide you with this quick guide for employers,…
Schrems II case – the data importer perspective Following our previous analysis of the consequences of the opinion of the advocate general Hendrik Saugmandsgaard Øe (a.g.) in the Schrems II case, from the data exporter perspective (available here), we now focus on the implications of the same with respect to…
Read publication What has happened? The German Federal Government has agreed on a draft bill amending the Circular…
In October 2019, the German Data Protection Authorities (“DPAs”) published guidelines on how they are going to determine…
Read publication Welcome to the October 2019 edition of our newsletter. The EMEA Healthcare Industry Group Newsletter is your regular digest of legal developments affecting the life science and healthcare industries across the region. In this issue: Europe • General presumption of confidentiality of clinical study reports: Opinion of AG…
Data has gone global. Whether you’re operating in one country or worldwide you need to know the local…
On October 2, 2019, the World Trade Organization (WTO) issued an arbitration decision in European Communities and Certain…
The EBA outsourcing guidelines came into effect on 30 September 2019. They are more prescriptive than the previous guidance and have a broader scope, applying to payment and e-money companies for the first time. All new outsourcing agreements entered into, reviewed or amended after 30 September 2019 should follow the…